Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center-Reference-Cited by-同舟云学术

Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center

Published:2023-01 Issue: Volume:370 Page:271-278
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Argirò Alessia,Zampieri Mattia,Dei Lorenzo-Lupo,Ferrantini Cecilia,Marchi Alberto,Tomberli Alessia,Baldini Katia,Cappelli Francesco,Favilli Silvia,Passantino Silvia,Zocchi Chiara,Tassetti Luigi,Gabriele Martina,Maurizi Niccolò,Marchionni Niccolò,Coppini Raffaele,Olivotto Iacopo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Clinical course and Management of Hypertrophic Cardiomyopathy. Longo DL, ed;Maron;N. Engl. J. Med.,2018

2. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines;Writing Committee Members;Circulation,2020

3. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: pathophysiology, assessment, and clinical impact;Aguiar Rosa;Microcirculation.,2021

4. Electrophysiological effects of Ranolazine, a novel antianginal agent with antiarrhythmic properties;Antzelevitch;Circulation.,2004

5. Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function;Belardinellia;Eur. Heart J. Suppl.,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ranolazine Unveiled: Rediscovering an Old Solution in a New Light;Journal of Clinical Medicine;2024-08-23

2. Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy;Frontiers in Pharmacology;2024-04-10

3. Metoprolol/nadolol/ranolazine;Reactions Weekly;2023-07-08

4. Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy;The International Journal of Cardiovascular Imaging;2023-06-26

5. Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report;Frontiers in Cardiovascular Medicine;2023-04-27